Introduction {#sec1}
============

There is a long-known adage, attributed to the famous English physician Thomas Sydenham (1624-1689): "you're only as old as your arteries". However, for many years only metrical age was used by clinicians trying to assess the cardiovascular risk of their patients via scales such as the Framingham scale. In this scale, used to calculate 10-year coronary risk, the age of patients is taken into account in addition to other factors. Nowadays it appears that although the calculated absolute risk values (especially among middle-aged patients) are often relatively low, the relative risk is unexpectedly high. Hence the idea of "cardiac age" or "coronary age" was born. It is still a relatively new concept. It seems that Grundy was the first to postulate in 1999 the use of biological age, based on evidence of arteriosclerosis, instead of the previously used chronological age, to estimate the cardiovascular risk by Framingham scale \[[@cit0001]\]. Although the advancement of atherosclerosis progresses with age, there is great individual variability at the onset and the speed of progression of atherosclerotic process. This may result in overestimation or underestimation of risk. That is why recently it has been postulated that arterial age be included in global risk scales.

Obesity is considered as a risk factor for the early development of atherosclerosis and cardiovascular disease. In recent studies not the total amount of body fat but rather its specific regional distribution is considered as a risk factors for cardiovascular disease. In this context, many studies have focused on intra-abdominal adipose tissue, which has features of an active endocrine gland and secretes a number of hormones and atherogenic cytokines known as adipokines \[[@cit0002]\]. Pericardial adipose tissue is considered a part of visceral fat, and it is believed that, in addition to systemic effects of adipokines, it can exert a local atherogenic effect on the coronary arteries \[[@cit0003]\]. Patients with morbid obesity are a special group of patients because they present multiple individual risk factors of atherosclerosis, some of which may enhance atherogenic effect due to interactions.

However, recently multiple reports have emerged, in which the direct association of obesity with the development of atherosclerosis is questioned. In some patients with obesity, and in some pathologies, an increased survival rate is observed compared to people with normal body mass. This phenomenon has been termed the "obesity paradox" or "reversed epidemiology". Such a paradoxical relationship of high body mass index (BMI) with better forecasts has already been described in patients with chronic renal disease, chronic heart failure, chronic obstructive pulmonary disease, and in patients with coronary heart disease \[[@cit0004]\]. This observation is explained by the fact that the nature and location of body fat, and not its total amount in the body, are risk factors for these diseases. Because subcutaneous adipose tissue is metabolically nearly inactive in comparison to visceral fat, its dominance in the body could actually explain the phenomenon of "reversed epidemiology". Recent studies have even shown that in healthy individuals, an increased amount of subcutaneous adipose tissue has a protective effect, inhibiting the development of atherosclerosis \[[@cit0005]\]. The phenomenon of the obesity paradox encourages further research, especially in the context of linking it with clusters of adipose tissue in particular areas of the body.

An aim of the study was to investigate the risk of CAD in morbidly obese patients using coronary artery calcium measurement.

Material and methods {#sec2}
====================

In this prospective study we evaluated 51 subjects with morbid obesity, who were scheduled for bariatric surgery procedures in our hospital. Inclusion criteria were as follows: morbid obesity (BMI ≥ 40 kg/m^2^) and lack of consistent effect of conservative treatment of obesity resulting in referral to bariatric surgery. Exclusion criteria included: body weight over 220 kg (scanner's table limit), inability to fit the scanner's gantry, dyspnoea in supine position, previous coronary stenting or coronary surgery, arrhythmia or tachycardia, pregnancy, and age below 18 years. Due to possible ethical concerns, a control group of 30 subjects was composed retrospectively of patients who were scanned due to clinical suspicion of coronary artery disease and who did not fulfil obesity criteria. Exclusion criteria were similar as in the study group. The study protocol was approved by a bioethical commission of our university, and all subjects gave their informed consent for participation in the study.

All subjects underwent an ECG-gated cardiac CT scanning according to the coronary calcium scoring protocol using a 64-row Philips Brilliance unit \[[@cit0006],[@cit0007]\]. Acquisition of data was performed in 2.5-mm slices at 120 kV and 75 mAs, with an FOV of 220 mm. No intravenous contrast media nor premedication were used. Standard Philips Brilliance Workstation with HeartBeat CS application were used to evaluate the presence and quantity of coronary artery calcium (CAC).

Measurement of the calcium score (CS) was carried out in a semi-automatic manner. In the initial stage the software distinguished calcifications on CT scans according to Agatston *et al*.'s criteria \[[@cit0008]\]. Then a reader was needed to identify coronary arteries at the axial cross-sections of the heart and to manually indicate highlighted calcifications. Other types of calcifications (such as calcified heart valves or picture noise erroneously classified by the algorithm as calcifications) were neglected by the reader. Then, the application automatically calculated Agatston's CS. Due to the high skewness of CS values, the data were log-transformed before statistical analysis \[[@cit0006]\].

Distribution of CS values within both groups was compared to the general population values using data from the German Multislice Normal Incidence of Coronary Health (MUNICH) Registry \[[@cit0009]\]. Apart from conventional CS, we also used coronary age (CA) as an alternative function of CAD risk. CA is defined as the age of a healthy person (without risk factors) who presents a risk of coronary heart disease equal to the risk calculated for the analysed patient. For example, if a coronary age of 65 years is calculated in 55-year-old patient, it means that the cardiovascular risk expressed by the amount of coronary calcifications is equal to that of a healthy 65-year-old individual. For the purpose of this study, patients' coronary age was determined by means of a commonly available on-line MESA-based tool \[[@cit0010],[@cit0011]\].

Quantitative variables were expressed as mean with 95% confidence intervals (95% CI). Statistical analysis was performed using MedCalc v. 14 (MedCalc Software bvba, NL). Normality of the data was tested using the Kolmogorov-Smirnov test. Differences in quantitative data were tested using the independent samples *t*-test. Comparison of qualitative data was performed using the Chi-squared test. *P*-values of 0.05 were considered statistically significant.

Results {#sec3}
=======

The participants were aged between 19 and 71 years (mean 46.8 years). Cardiac CT scanning was completed in all subjects without premedication. The mean heart rate during the acquisition was 73 BPM. Both groups statistically significantly differed regarding body weight, height, and BMI. Common risk factors for atherosclerosis, i.e. hypertension, diabetes, nicotine, and dyslipidaemia, were more frequent in the control group than in obese patients, and only in the case of diabetes was the difference not statistically significant. Detailed demographic characteristics of the study groups are given in [Table 1](#t0001){ref-type="table"}.

###### 

Demographic characteristics of the study groups. Mean values (95% confidence interval) or structural indices and *p*-values for the differences are given

  Parameter              Study group           Control group      *p*
  ---------------------- --------------------- ------------------ --------
  Gender (females)       66.7%                 60.0%              0.0663
  Metrical age (years)   44.1 (40.9-47.3)      51.8 (47.9-55.7)   0.0723
  Body weight \[kg\]     128.9 (124.1-133.8)   76.5 (71.4-81.6)   0.0000
  Height \[m\]           1.65 (1.63-1.67)      1.70 (1.67-1.73)   0.0024
  BMI                    47.3 (45.7-48.9)      26.5 (24.9-28.0)   0.0000
  Hypertension           35%                   70%                0.0023
  Diabetes               18%                   30%                0.2113
  Smoking                16%                   43%                0.0075
  Dyslipidaemia          22%                   47%                0.0191

The prevalence of CAC was higher in morbidly obese patients than in controls (*p* = 0.0091) ([Table 2](#t0002){ref-type="table"}). In the obesity group, calcifications were detected in 27 individuals, and CS ranged from 1 to 2453. A value greater than the 50^th^ centile was reached by 51% of subjects ([Figure 1](#f0001){ref-type="fig"}). The CA of patients ranged from 19 to 96 years, and 47% of the patients were above the metrical age ([Figure 2](#f0002){ref-type="fig"}). In the control group, calcifications were detected in seven subjects, and CS ranged from 1 to 346. Only 23% of controls had CAC over the 50^th^ centile ([Figure 1](#f0001){ref-type="fig"}). The majority (63%) of controls had CA lower than their metrical age ([Figure 2](#f0002){ref-type="fig"}).

###### 

Results of measurement of coronary calcifications. Mean values (95% confidence interval) or structure index and significance level in *t*-test are given

  Parameter                                                Study group         Control group              *p*
  -------------------------------------------------------- ------------------- -------------------------- --------
  Prevalence of calcifications                             52.9%               23.3%                      0.0091
  Calcium score                                            91.9 (0.0-189.4)    45.6 (8.2-83.0)            0.0661
  Coronary age \[years\]                                   49.6 (44.9-54.4)    47.0 (41.3-52.7)           0.5057
  Difference between coronary and metrical age \[years\]   +5.55 (1.51-9.59)   --4.77 (--10.02; --0.48)   0.0023

![Percentile distribution of calcium score (CS) values in the study group and the control group, according to MUNICH registry](PJR-83-78624-g001){#f0001}
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The mean number of calcifications was higher in the study group than in the control group, but the difference was of borderline significance. However, the difference between coronary age and metrical age was significantly higher in obese patients than in controls (*p* = 0.0023) ([Table 2](#t0002){ref-type="table"}). The ROC curve analysis confirmed that the difference between CA and metrical age presented the strongest relation with obesity ([Table 3](#t0003){ref-type="table"}).

###### 

Analysis of the ROC curve for the relationship between obesity and analysed morphological parameters. Only statistically significant relationships are shown

  Parameter                                                AUC (95% CI)       *p*         Threshold   Sensitivity   Specificity
  -------------------------------------------------------- ------------------ ----------- ----------- ------------- -------------
  Prevalence of coronary calcifications                    0.64 (0.53-0.75)   0.0069      \> 0        52            77
  Calcium score                                            0.63 (0.52-0.74)   0.0302      \> 0.1      58            77
  Coronary age \[years\]                                   0.71 (0.60-0.81)   \< 0.0001   ≤ 44        58            90
  Difference between coronary and metrical age \[years\]   0.72 (0.61-0.81)   0.0005      \> --6      82            63

Discussion {#sec4}
==========

In our study we showed that patients with morbid obesity present an increased coronary age. In this study, the number of calcifications in the coronary arteries and derivative parameters were adopted as the primary indicators of risk for atherosclerosis. Our results indicate that obesity is associated with an increased risk of coronary atherosclerosis, which is reflected by a higher incidence of calcification in the study group compared to the control group. Interestingly, the difference between CA and metrical age presented the strongest relation to obesity. Therefore, it may be concluded that this parameter potentially may become a useful method for estimating the risk of cardiovascular events in people with extreme obesity. It also seems to be a unique finding because, according to our knowledge, the concept of the difference between coronary and metrical age has not been studied before.

Calcium scoring has been shown to be reproducible and predictive of a variety of adverse outcomes of CAD. Moreover, progression of calcifications correlates with severity of CAD, which adds to the predictive value of this test \[[@cit0009],[@cit0010]\]. Of course, coronary computed tomography angiography (CTA) would offer much more information on the status of coronary arteries than calcium scoring. However, the main drawbacks of CTA include much higher radiation dose and the risk of contrast-induced nephropathy (CIN) \[[@cit0012]\], which makes CTA inefficient as a screening tool. CIN is of particular importance because atherosclerosis remains an important risk factor of this pathology \[[@cit0012]\]. Nevertheless, little is known about the impact of obesity on the early development of atherosclerosis. The early studies, such as the Seven Countries Study (1984), revealed only a negligible correlation between body weight and the incidence of coronary heart disease. In the Pathological Determinants of Atherosclerosis in Youth (PDAY) study, BMI and subcutaneous fat thickness were positively correlated with the pathomorphological signs of early atherosclerosis in young men, but not in young women \[[@cit0013]\]. However, the large MESA study indicated that obesity is associated with an increased risk of atherosclerosis, which manifested, among others, by 1.2-fold higher incidence of calcification in the coronary arteries in obese patients compared with people of normal weight \[[@cit0014]\]. Today, the efforts of researchers tend to focus on determining the impact of the regional distribution of fat and subtypes of fat on the development of atherosclerosis. Among the available publications, particularly noteworthy is the work of Gadelha *et al*., who conducted their research on a population similar to ours, i.e. patients without known coronary artery disease, scheduled for bariatric surgery. The researchers noticed the presence of coronary CAC in 14% of participants, including 26% of men and 11% of women. They also underlined that the study participants with CAC were generally older (average age 46.8 years) than patients without calcifications in the coronary arteries (mean age 34.3 years). Other variables, showing the relationship with the CAC, included: male gender, type 2 diabetes, hypertension, and hypercholesterolaemia \[[@cit0015]\]. In our own material, calcifications in the coronary arteries in morbidly obese patients occurred much more frequently (52.9%), wherein our patients were more obese than in the above-quoted paper (mean BMI was 47.3 vs. 40.5). Similarly, the results of the cohort, long-term CARDIA (Coronary Artery Risk Development in Young Adults) study suggested that abdominal obesity, assessed by waist circumference and waist-hip ratio (WHR) in young adults during a 15-year follow-up period, was directly linked with a higher incidence of coronary atherosclerosis \[[@cit0016]\]. Similar results were seen in the St. Francis Heart Study, in which abdominal obesity evaluated with WHR and amount of visceral fat positively correlated with the amount of CAC in people aged 50-70 years \[[@cit0017]\]. Meanwhile, Cassidy *et al*. analysed the coincidence of coronary calcifications with, for example, abdominal circumference, WHR, and BMI and discovered that expected annual growth of CAC in overweight people is about 51% higher than in people with underweight and normal weight \[[@cit0018]\]. In turn, the Muscatine Study demonstrated that excessive weight gain during childhood (8-18 years) and the calculated BMI in the age of 20-34 years were positively associated with the presence of calcifications in the coronary arteries later in life, i.e. in the age range 29-37 years \[[@cit0019]\].

The literature review gives grounds to believe that the vascular age indeed allows us to improve the efficiency of determining the cardiovascular risk. For example, Shaw *et al*. utilised CAC measurements performed in a group of 10,377 asymptomatic participants in order to assess the risk of death and then the number of life-years lost. Their results indicated a direct relationship between chronological age and the number of calcifications in the coronary arteries, and also allowed them to create their own linear predictive model. According to the researchers, CS below 10 in patients aged over 70 years was equivalent to a reduction in biological age by 10 years. In contrast, CS \> 400 in younger patients "added" up to 30 years of chronological age. In their material, the age modified in relation to the number of calcifications was also a better predictor of mortality than chronological age. With regard to the Framingham scale, utilisation of the modified age resulted in reclassification of patients from a low-risk to an intermediate risk group in 55% of cases, and 45% of those at medium risk to high risk \[[@cit0020]\]. Similar results were obtained by Nasir *et al*. In their material, CS ranging from the 75^th^ to the 90^th^ percentiles added 10 years to metrical age, while exceeding the 90^th^ percentile increased the age by 20 years. In contrast, in patients in age where the CS \> 0 falls within the normal range (i.e. in men above the age of 55 and in women above the age of 65 years), CS = 0 reduced the age to 40-44 years and 55-59 years, respectively \[[@cit0021]\].

There are also limitations to our study that should be addressed. Firstly, our sample size was calculated with assumption for the largest possible effect. This might have led to the underestimation of the sample size to get statistical significance of the difference in the total CAC load. In fact, the difference in CS between the obesity group and control group is large and should be statistically significant when including a larger number of subjects. Secondly, selection of the control group should be discussed. Due to ethical concerns, exposition of healthy individuals to the radiation was not acceptable. Therefore, we used a group of subjects who were scheduled for a diagnostic coronary CT angiography. As a result, our control group participants might have more risk factors of atherosclerosis. To compensate for this we used centile ranks based on the MESA study as a reference. On the other hand, because our controls were slightly older than obesity patients, a direct comparison of CA showed a non-significant difference. Therefore, we used the difference between CA and metrical age as the method of coronary risk estimation. Finally, we used a CA estimation system based on the American population, which is more heterogeneous than the European one. However, this discrepancy might not limit the soundness of our conclusions because in general Americans tend to present no less risk of CAD than Europeans.

Conclusions {#sec5}
===========

We found that morbid obesity is associated with an increased coronary age, which may reflect the raised cardiovascular risk in obese patients. However, further studies on larger populations and with follow-up are necessary to determine the actual usefulness of coronary age in the prediction of cardiovascular events.
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